Concentrix Corporation $CNXC Holdings Boosted by Hussman Strategic Advisors Inc.

Key Points

• Hussman Strategic Advisors doubled its stake in Concentrix to 84,000 shares during Q4, making CNXC the firm's 11th-largest holding and representing 0.8% of its portfolio.
• Major insider sale: Bruxelles Lambert Groupe sold 6,000,000 shares for roughly $133.5 million, cutting its stake by about 68.4%, a significant reduction by a large shareholder.
• Mixed fundamentals: Concentrix slightly missed Q1 EPS expectations, reported a negative net margin (-13.35%) while revenue rose 5.4% year‑over‑year, and declared a $0.36 quarterly dividend (≈5.9% yield).

Hussman Strategic Advisors Inc. boosted its position in shares of Concentrix Corporation (NASDAQ:CNXC - Free Report) by 100.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 84,000 shares of the company's stock after purchasing an additional 42,000 shares during the period. Concentrix accounts for 0.8% of Hussman Strategic Advisors Inc.'s investment portfolio, making the stock its 11th biggest holding. Hussman Strategic Advisors Inc. owned 0.14% of Concentrix worth $3,493,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CNXC. Huntington National Bank grew its position in Concentrix by 6,011.1% during the 3rd quarter. Huntington National Bank now owns 550 shares of the company's stock worth $25,000 after purchasing an additional 541 shares in the last quarter. Quent Capital LLC purchased a new position in Concentrix during the 3rd quarter worth approximately $29,000. Larson Financial Group LLC grew its position in Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company's stock worth $32,000 after purchasing an additional 479 shares in the last quarter. Geneos Wealth Management Inc. grew its position in Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock worth $34,000 after purchasing an additional 522 shares in the last quarter. Finally, Rothschild Investment LLC grew its position in Concentrix by 14,980.0% during the 3rd quarter. Rothschild Investment LLC now owns 754 shares of the company's stock worth $35,000 after purchasing an additional 749 shares in the last quarter. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Concentrix Trading Up 3.0%

Concentrix stock opened at $24.53 on Friday. The company's fifty day simple moving average is $29.47 and its 200-day simple moving average is $35.89. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.43. Concentrix Corporation has a 12 month low of $22.85 and a 12 month high of $62.14. The stock has a market cap of $1.50 billion, a P/E ratio of -1.14, a P/E/G ratio of 0.31 and a beta of 0.37.

Concentrix (NASDAQ:CNXC - Get Free Report) last posted its quarterly earnings results on Tuesday, March 24th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.65 by ($0.04). Concentrix had a negative net margin of 13.35% and a positive return on equity of 17.80%. The company had revenue of $2.50 billion for the quarter, compared to analysts' expectations of $2.49 billion. During the same quarter in the prior year, the firm earned $2.79 earnings per share. The company's revenue was up 5.4% on a year-over-year basis. As a group, sell-side analysts forecast that Concentrix Corporation will post 10.42 EPS for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 5th. Investors of record on Friday, April 24th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, April 24th. Concentrix's payout ratio is presently -6.68%.

Insider Buying and Selling at Concentrix

In other Concentrix news, CFO Andre S. Valentine acquired 2,500 shares of Concentrix stock in a transaction that occurred on Thursday, April 9th. The stock was acquired at an average price of $27.95 per share, with a total value of $69,875.00. Following the purchase, the chief financial officer owned 89,066 shares in the company, valued at approximately $2,489,394.70. This trade represents a 2.89% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of Concentrix stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the completion of the sale, the insider directly owned 2,773,667 shares of the company's stock, valued at approximately $61,714,090.75. The trade was a 68.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.90% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms have weighed in on CNXC. Canaccord Genuity Group lowered their price objective on shares of Concentrix from $80.00 to $55.00 and set a "buy" rating on the stock in a research report on Wednesday, March 25th. Barrington Research lowered their price objective on shares of Concentrix from $62.00 to $38.00 and set an "outperform" rating on the stock in a research report on Wednesday, March 25th. Wall Street Zen cut shares of Concentrix from a "buy" rating to a "hold" rating in a research report on Saturday, March 28th. Weiss Ratings reiterated a "sell (d)" rating on shares of Concentrix in a research report on Monday, April 27th. Finally, Robert W. Baird lowered their price objective on shares of Concentrix from $52.00 to $40.00 and set an "outperform" rating on the stock in a research report on Wednesday, March 25th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $48.50.

Concentrix Company Profile

Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.